Vyome Therapeutics

company

About

Vyome Therapeutics is an innovation driven company, with a vision to develop novel treatments for resistant pathogens

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$8M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Vyome Biosciences is an innovation driven company, with a vision to
develop novel drugs for antibiotics-resistant acne and other opportunist
pathogens through a unique pipeline of antibiotics that retard resistance
development.

Vyome Biosciences’ management team members are the leaders in the field,
with deep expertise, demonstrated capability and a proven track record of
successfully launching over 50 products in dermatology & other life
sciences areas, and building visionary companies.

Vyome’s development platform is completely risk mitigated. Vyome has a deep
pipeline of IP based products targeting multiple indications. The *lead
molecule (VB 1953)*, which targets the huge unmet need in the drug
resistant acne prescription market, will be entering the clinical phase
with *USFDA IND Application Filing in Q4 2015*.

Vyome has state-of-the-art infrastructure facilities to carry out all its
research and lab development work, with full-fledged formulation,
analytical, chemistry, biology & molecular biology, clinical and the
regulatory divisions. The infrastructure and the team enables Vyome to
conceive ideas, develop them and commercialize them at a rapid pace.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$25.30M ₹1.54B
Vyome Therapeutics has raised a total of $25.30M ₹1.54B in funding over 2 rounds. Their latest funding was raised on Jan 3, 2019 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 3, 2019 Series D ₹1.54B 1 Detail
Aug 22, 2016 Series C $14M 1 Detail
Aug 12, 2014 Series B $8M 1 Detail
Sep 12, 2012 Series A $3.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Vyome Therapeutics is funded by 1 investors. Kalaari Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kalaari Capital Series D